CMRA logo

CMRA

Profile

Full Name

Comera Life Sciences Holdings, Inc.

Ticker Symbol

CMRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 21, 2020

Indexes

Not included

Website

http://comeralifesciences.com

Employees

12

Key Details

Price

$0.00(0.00%)

Market cap

$6147.56(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$633.10K(+97.97% YoY)

Annual EPS

-$1.76(-516.25% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.00
CMRA price is $0.00

30-Day Relative Volume

0.00
CMRA 30-day relative volume is 0.00

Price Performance

Price Most recent change

0%
CMRA {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

0%
CMRA {parameterFullLabel} has remained unchanged since January 1st

Price 1-year change

-99.47%
CMRA price is down -99.47% year-on-year

Price 3-year change

-100%
CMRA price is down -100% over the past 3 years

Price Range

Price All-time high

$15.30
CMRA price is currently -100.00% below its historical high of $15.30

Price 3-year low

$0.00
CMRA price is currently +100.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$6147.56
CMRA market capitalization is $6147.56

Market cap 3-year change

-
CMRA market capitalization 3-year change is unknown

Market cap All-time high

$168.92M
CMRA market capitalization is currently -100.00% below its historical high of $168.92 million

Market cap sector rank

1.4%
CMRA market capitalization is higher than 1.4% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
CMRA {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

-
CMRA shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

14.85
CMRA beta is 14.85

200-day SMA

$0.01
CMRA price is currently -97.70% below its 200-day simple moving average

50-day SMA

$0.00
CMRA price is currently equal to its 50-day simple moving average

RSI

50.00
CMRA 14-day relative strength index is 50.00

Volume

0.00
CMRA 30-day relative volume is 0.00

ATR

$0.00
CMRA average true range is $0.00

10-day Historical Volatility

0.00%
CMRA 10-day historical volatility is 0.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$633.10K
CMRA annual revenue is $633.10 thousand

Revenue Analysts estimate

-
CMRA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+97.97%
CMRA annual revenue is up +97.97% year-on-year

Revenue Sector rank

10.86%
CMRA annual revenue is higher than 10.86% of companies in Healthcare sector

EPS

EPS

-$1.76
CMRA annual earnings per share is -$1.76

EPS Analysts estimate

-
CMRA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-516.25%
CMRA annual earnings per share is down -516.25% year-on-year

EPS Sector rank

40.88%
CMRA annual earnings per share is higher than 40.88% of companies in Healthcare sector

Profit

Gross profit

$422.70K
CMRA annual gross profit is $422.70 thousand

Gross margin

66.77%
CMRA annual gross profit margin is 66.77%

Operating profit

-$11.97M
CMRA annual operating income is -$11.97 million

Operating margin

-1890.69%
CMRA annual operating profit margin is -1890.69%

Net income

-$18.00M
CMRA annual net profit is -$18.00 million

Net margin

-2843.79%
CMRA annual net profit margin is -2843.79%

Expenses

Total expenses

$12.60M
CMRA annual total expenses is $12.60 million

Operating expenses

$12.39M
CMRA annual total operating expenses is $12.39 million

Cost of goods sold

$210.40K
CMRA annual cost of goods sold is $210.40 thousand

Selling, general & administrative expenses

$10.65M
CMRA annual SGA is $10.65 million

Depreciation and amortization

$93.90K
CMRA annual depreciation & amortization is $93.90 thousand

Interest expense

$20.40K
CMRA annual interest expense is $20.40 thousand

Income tax

-
CMRA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$17.98M
CMRA annual earnings before interest & taxes is -$17.98 million

EBITDA

-$17.89M
CMRA annual EBITDA is -$17.89 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.73M
CMRA annual total assets is $3.73 million

Non current assets

$664.00K
CMRA annual long term assets is $664.00 thousand

Current assets

$3.06M
CMRA annual total current assets is $3.06 million

Cash and cash equivalents

$446.60K
CMRA annual cash & cash equivalents is $446.60 thousand

Accounts receivable

$34.30K
CMRA annual accounts receivable is $34.30 thousand

Inventory

-
CMRA annual inventory value is unknown

Liabilities

Total liabilities

$9.97M
CMRA annual total liabilities is $9.97 million

Long term liabilities

$4.92M
CMRA annual total long term liabilities is $4.92 million

Current liabilities

$5.06M
CMRA annual total current liabilities is $5.06 million

Accounts payable

$1.46M
CMRA annual accounts payable is $1.46 million

Debt

Total debt

$775.00K
CMRA annual total debt is $775.00 thousand

Total debt 1-year change

+139.86%
CMRA annual total debt is up +139.86% year-on-year

Long term debt

$120.30K
CMRA annual long term debt is $120.30 thousand

Short term debt

$654.70K
CMRA annual short term debt is $654.70 thousand

Equity & Capital

Shareholders equity

-$6.25M
CMRA annual stockholders equity is -$6.25 million

Book value

-$6.25M
CMRA annual book value is -$6.25 million

Retained earnings

-$34.90M
CMRA annual retained earnings is -$34.90 million

Working capital

-$2.00M
CMRA annual working capital is -$2.00 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$9.77M
CMRA annual cash flow from operations is -$9.77 million

Cash from operations 1-year change

-160.03%
CMRA annual cash flow from operations is down -160.03% year-on-year

Cash from investing

-$28.60K
CMRA annual cash flow from investing activities is -$28.60 thousand

Cash from investing 1-year change

+79.86%
CMRA annual cash flow from investing activities is up +79.86% year-on-year

Cash from financing

$5.24M
CMRA annual cash flow from financing activities is $5.24 million

Cash from financing 1-year change

-49%
CMRA annual cash flow from financing activities is down -49% year-on-year

CAPEX

CAPEX

$28.60K
CMRA annual capital expenditures is $28.60 thousand

CAPEX 1-year change

-79.86%
CMRA annual capital expenditures is down -79.86% year-on-year

Free Cash Flow

Free cash flow

-$9.80M
CMRA annual free cash flow is -$9.80 million

Free cash flow 1-year change

-151.29%
CMRA annual free cash flow is down -151.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

66.77%
CMRA annual gross profit margin is 66.77%

Operating margin

-1890.69%
CMRA annual operating profit margin is -1890.69%

Net margin

-2843.79%
CMRA annual net profit margin is -2843.79%

ROA & ROE

ROA

-323.09%
CMRA annual return on assets is -323.09%

ROE

288.20%
CMRA annual return on equity is 288.20%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CMRA price to earnings ratio value is unknown

PE ratio Sector rank

-
CMRA price to earnings ratio is unknown

PB Ratio

PB ratio

0.00
CMRA price to book ratio is 0.00

PB ratio Sector rank

16.69%
CMRA price to book ratio is higher than 16.69% of companies in Healthcare sector

PS Ratio

PS ratio

0.01
CMRA price to sales ratio is 0.01

PS ratio Sector rank

2.05%
CMRA price to sales ratio is higher than 2.05% of companies in Healthcare sector

Enterprise value

Enterprise value

-$1.59M
CMRA enterprise value is -$1.59 million

Enterprise value Sector rank

9.33%
CMRA enterprise value is higher than 9.33% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.18
CMRA EV/EBITDA is 0.18

EV/EBITDA Sector rank

68.98%
CMRA EV/EBITDA is higher than 68.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.61
CMRA annual current ratio is 0.61

Quick ratio

-
CMRA annual quick ratio value is unknown

Leverage

Debt to equity

-0.07
CMRA annual debt to equity ratio is -0.07

Interest coverage ratio

-881.55
CMRA annual interest coverage ratio is -881.55

Risk & Stability

Piotroski F-Score

3
CMRA piotroski f-score is 3

Altman Z-Score

-29.51
CMRA altman z-score is -29.51

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

NMRD logo
Nemaura Medical (NMRD)
STAB logo
Statera Biopharma (STAB)
CALA logo
Calithera Biosciences (CALA)
ARDS logo
Aridis Pharmaceuticals (ARDS)
EVLO logo
Evelo Biosciences (EVLO)
BTTX logo
Better Therapeutics (BTTX)
BIMI logo
BIMI International Medical (BIMI)
THMO logo
ThermoGenesis Holdings (THMO)
AMPE logo
Ampio Pharmaceuticals (AMPE)
  • What is the ticker symbol for Comera Life Sciences Holdings?
  • Does Comera Life Sciences Holdings pay dividends?
  • What sector is Comera Life Sciences Holdings in?
  • What industry is Comera Life Sciences Holdings in?
  • What country is Comera Life Sciences Holdings based in?
  • When did Comera Life Sciences Holdings go public?
  • Is Comera Life Sciences Holdings in the S&P 500?
  • Is Comera Life Sciences Holdings in the NASDAQ 100?
  • Is Comera Life Sciences Holdings in the Dow Jones?
  • When was Comera Life Sciences Holdings's last earnings report?
  • When does Comera Life Sciences Holdings report earnings?

What is the ticker symbol for Comera Life Sciences Holdings?

The ticker symbol for Comera Life Sciences Holdings is NASDAQ:CMRA

Does Comera Life Sciences Holdings pay dividends?

No, Comera Life Sciences Holdings does not pay dividends

What sector is Comera Life Sciences Holdings in?

Comera Life Sciences Holdings is in the Healthcare sector

What industry is Comera Life Sciences Holdings in?

Comera Life Sciences Holdings is in the Biotechnology industry

What country is Comera Life Sciences Holdings based in?

Comera Life Sciences Holdings is headquartered in United States

When did Comera Life Sciences Holdings go public?

Comera Life Sciences Holdings's initial public offering (IPO) was on December 21, 2020

Is Comera Life Sciences Holdings in the S&P 500?

No, Comera Life Sciences Holdings is not included in the S&P 500 index

Is Comera Life Sciences Holdings in the NASDAQ 100?

No, Comera Life Sciences Holdings is not included in the NASDAQ 100 index

Is Comera Life Sciences Holdings in the Dow Jones?

No, Comera Life Sciences Holdings is not included in the Dow Jones index

When was Comera Life Sciences Holdings's last earnings report?

Comera Life Sciences Holdings's most recent earnings report was on Mar 16, 2023

When does Comera Life Sciences Holdings report earnings?

The date for Comera Life Sciences Holdings's next earnings report has not been announced yet
On this page